Jun 01, 2018 - Nektar (NKTR) submits NDA to the FDA seeking approval of its analgesic opioid candidate, NKTR-181, for the treatment of chronic low back pain.
May 31, 2018 - This company hopes to profit from shaking up how doctors treat lower back pain.
May 31, 2018 - The biggest cancer meeting of the year is upon us, with updates on clinical trials.
May 30, 2018 - The bar for what's considered successful keeps rising, as does the number of potential competitors.
May 30, 2018 - Pfizer's (PFE) lung cancer drug, Xalkori (crizotinib), gets Breakthrough Therapy designation by the FDA for two new indications.
May 30, 2018 - These drugs made billions of dollars last year by treating relatively small numbers of patients.
May 29, 2018 - Roche's (RHHBY) Tecentriq meets its co-primary endpoints of overall survival and progression-free survival in a phase III study for lung cancer.
May 28, 2018 - Bristol-Myers Squibb (BMY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
May 28, 2018 - AstraZeneca Plc. (AZN) announces positive overall survival (OS) data from an interim analysis of a phase III PACIFIC study evaluating its oncology candidate, Imfinzi.
May 24, 2018 - Merck's (MRK) Keytruda in combination with chemotherapy demonstrates better OS and PFS in first-line metastatic squamous NSCLC compared to chemotherapy alone.